Glioblastoma Multiforme (GBM) is one of the most aggressive forms of brain cancer, with limited treatment options and poor survival outcomes. The glioblastoma multiforme survival rate remains low, prompting researchers to explore innovative treatment solutions. The glioblastoma market by t